References
- Ram F S, Wright J, Brocklebank D, White J E. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering beta (2 )agonists bronchodilators in asthma. BMJ 2001; 323(7318)901–905, [PUBMED], [INFOTRIEVE]
- Cates C J, Rowe B H, Bara A. Holding chambers versus nebulisers for beta‐agonist treatment of acute asthma. Cochrane Database of Systematic Reviews. Update Software, Oxford 2002
- Dockhorn R, Vanden Burgt J A, Ekholm B P, Donnell D, Cullen M T. Clinical equivalence of a novel non‐chlorofluorocarbon‐containing salbutamol sulfate metered‐dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma. J Allergy Clin Immunol 1995; 96(1)50–56, [PUBMED], [INFOTRIEVE]
- Kleerup E C, Tashkin D P, Cline A C, Ekholm B P. Cumulative dose‐response study of non‐CFC propellant HFA 134a salbutamol sulfate metered‐dose inhaler in patients with asthma. Chest 1996; 109(3)702–707, [PUBMED], [INFOTRIEVE]
- Bleecker E R, Tinkelman D G, Ramsdell J, Ekholm B P, Klinger N M, Colice G L, Slade H B. Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics. Chest 1998; 113(2)283–289, [PUBMED], [INFOTRIEVE]
- Ramsdell J W, Colice G L, Ekholm B P, Klinger N M. Cumulative dose response study comparing HFA‐134a albuterol sulfate and conventional CFC albuterol in patients with asthma. Ann Allergy Asthma Immunol 1998; 81(6)593–599, [PUBMED], [INFOTRIEVE]
- Baumgarten C R, Dorow P, Weber H H, Gebhardt R, Kettner J, Sykes A P. Equivalence of as‐required salbutamol propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. German Study Group. Respir Med 2000; 94(suppl B)S17–S21, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bamber M G. Difficulties with CFC‐free salbutamol inhaler. Lancet 1996; 348(9043)1737, [PUBMED], [INFOTRIEVE]
- Slader C A, Reddel H K, Bosnic‐Anticevich S Z. Lack of awareness of need to clean CFC‐free metered dose inhalers. J Asthma 2004; 41(3)367–373, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ley P. Memory for medical information. Br J Soc Clin Psychol 1979; 18(2)245–255, [PUBMED], [INFOTRIEVE]
- National Asthma Education and Prevention Program. Expert panel report 2. Guidelines for the Diagnosis and Management of Asthma. NHLBI, NIH, Bethesda, MD 1997
- British Pharmacopoeia. Preparations for Inhalation. H.M.S.O Limited, NorwichUK 2001, Available at http://www.pharmacopoeia.co.uk/index.html. Accessed October 2002
- Prime D, Grant A C, Slater A L, Woodhouse R N. A critical comparison of the dose delivery characteristics of four alternative inhalation devices delivering salbutamol: pressurized metered dose inhaler, Diskus inhaler, Diskhaler inhaler, and Turbuhaler inhaler. J Aerosol Med 1999; 12(2)75–84, [PUBMED], [INFOTRIEVE]
- British Pharmacopoeia. Salbutamol Pressurised Inhalation. H.M.S.O. Limited, NorwichUK 2001, Available at http://www.pharmacopoeia.co.uk/index.html. Accessed October 2002
- Rees P J, Clark T J, Moren F. The importance of particle size in response to inhaled bronchodilators. Eur J Respir Dis, Suppl 1982; 119: 73–78
- Ross D L, Gabrio B J. Advances in metered dose inhaler technology with the development of a chlorofluorocarbon‐free drug delivery system. J Aerosol Med 1999; 12(3)151–160, [PUBMED], [INFOTRIEVE]
- Cripps A, Riebe M, Schulze M, Woodhouse R. Pharmaceutical transition to non‐CFC pressurized metered dose inhalers. Respir Med 2000; 94(suppl B)S3–S9, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Blake K V, Harman E, Hendeles L. Evaluation of a generic albuterol metered‐dose inhaler: importance of priming the MDI. Ann Allergy 1992; 68: 169–174, [PUBMED], [INFOTRIEVE]
- Ayres J G, Frost C D, Holmes W F, Williams D RR, Ward S M. Response to correspondence by Bamber. BMJ 1999; 318: 810